NCT06429774 Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)
| NCT ID | NCT06429774 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tiantan Hospital |
| Condition | Traumatic Brain Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-08-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective, multicenter, observational cohort study is designed to compare the effectiveness of intervention in multi-grade hospitals for acute traumatic brain injury and to optimize clinical outcomes.
Eligibility Criteria
Inclusion Criteria: * Patient (1 years to 89 years) presenting with clinical symptoms of traumatic brain injury * Traumatic brain injury verified on cranial computed tomography or magnetic resonance imaging * Written informed consent from patients or their next of kin according to the patient's cognitive status Exclusion Criteria: * patients ≥90 years of age * patients who did not accept follow-up visits or were unable to complete follow-up assessments * patients with incomplete information * patients who did not obtain written informed consent * patients with concomitant cancer or other serious illnesses
Contact & Investigator
Weiming Liu, M.D.
PRINCIPAL INVESTIGATOR
Beijing Tiantan Hospital
Frequently Asked Questions
Who can join the NCT06429774 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 89 Years, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06429774 currently recruiting?
Yes, NCT06429774 is actively recruiting participants. Contact the research team at liuweimingnsok@sina.com for enrollment information.
Where is the NCT06429774 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China, Beijing, China, Beijing, China and 11 additional locations.
Who is sponsoring the NCT06429774 clinical trial?
NCT06429774 is sponsored by Beijing Tiantan Hospital. The principal investigator is Weiming Liu, M.D. at Beijing Tiantan Hospital. The trial plans to enroll 2,000 participants.